Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5281 to 5295 of 8314 results

  1. What is the clinical and cost effectiveness of inpatient rehabilitation provided by the independent sector compared with that provided by the NHS?

    Recommendation ID NG181/5 Question What is the clinical and cost effectiveness of inpatient rehabilitation provided by the independent

    Research recommendation
    Published
    26 October 2020

  2. In patients hospitalised with moderate- to high-severity community-acquired pneumonia, does using C-reactive protein monitoring in addition to clinical observation to guide antibiotic duration safely reduce the total duration of antibiotic therapy compared with a fixed empirical antibiotic course?

    Recommendation ID CG191/2 Question In patients hospitalised with moderate- to high-severity community-acquired pneumonia, does using C-reactive

    Research recommendation
    Published
    9 June 2015

  3. In patients with muscle-invasive bladder cancer suitable for radical treatment, does the use of biomarkers enable patients to select more effective treatment, and improve their outcomes, compared with treatment selected without biomarkers?

    Recommendation ID NG2/4 Question In patients with muscle-invasive bladder cancer suitable for radical treatment, does the use of biomarkers

    Research recommendation
    Published
    9 June 2015

  4. The effect of drug therapy for concurrent conditions on melanoma survival: In people diagnosed with melanoma what is the effect of drug therapy to treat concurrent conditions on disease specific survival? This should be investigated in a national prospective cohort study. Secondary outcomes should include overall survival and quality of life.

    Recommendation ID NG14/10 Question The effect of drug therapy for concurrent conditions on melanoma survival: In people diagnosed with

    Research recommendation
    Published
    4 August 2022

  5. Pharmacological prevention: In people in hospital who are at high risk of delirium, which medication (atypical antipsychotics, typical antipsychotics, benzodiazepines or acetylcholinesterase inhibitors), compared with placebo or each other, is more clinically and cost effective in preventing the development of delirium?

    Recommendation ID CG103/02 Question Pharmacological prevention: In people in hospital who are at high risk of delirium, which medication

    Research recommendation
    Published
    3 February 2023

  6. Pharmacological treatment: In people in hospital who have delirium, which is the most effective medication (atypical antipsychotics, typical antipsychotics or benzodiazepines) compared with placebo or each other for treating delirium?

    Recommendation ID CG103/03 Question Pharmacological treatment: In people in hospital who have delirium, which is the most effective medication

    Research recommendation
    Published
    3 February 2023

  7. How can the effectiveness of workplace health policies and programmes be measured?

    Recommendation ID NG13/3 Question How can the effectiveness of workplace health policies and programmes be measured? Any explanatory

    Research recommendation
    Published
    5 October 2015

  8. How can the factors that pose a risk to, or protect, the social and emotional wellbeing of children aged under 5 years be identified and assessed to determine how children can benefit from different interventions?

    Recommendation ID PH40/2 Question How can the factors that pose a risk to, or protect, the social and emotional wellbeing of children aged

    Research recommendation
    Published
    9 June 2015

  9. How can the implementation of the recommendations made in this guideline be evaluated?

    Recommendation ID NG13/1 Question How can the implementation of the recommendations made in this guideline be evaluated? Any explanatory

    Research recommendation
    Published
    5 October 2015

  10. How can the uptake of hepatitis C treatment be improved? What factors influence whether or not specific groups at increased risk will begin and complete hepatitis C treatment?

    Recommendation ID PH43/2 Question How can the uptake of hepatitis C treatment be improved? What factors influence whether or not specific

    Research recommendation
    Published
    9 June 2015

  11. Independent advocacy: How can the views of babies, children and young people be best represented by independent advocates?

    Recommendation ID NG204/2 Question Independent advocacy: How can the views of babies, children and young people be best represented by

    Research recommendation
    Published
    30 September 2021

  12. Delirium in long-term care: How common is delirium and what are its adverse outcomes in people in long-term care?

    Recommendation ID CG103/05 Question Delirium in long-term care: How common is delirium and what are its adverse outcomes in people in long-term

    Research recommendation
    Published
    3 February 2023

  13. How cost effective are alternative testing sites, such as community pharmacist programmes, for increasing the number of people who are tested and treated for hepatitis B and C?

    Recommendation ID PH43/5 Question How cost effective are alternative testing sites, such as community pharmacist programmes, for increasing

    Research recommendation
    Published
    9 June 2015

  14. How cost effective are cohort testing programmes: - as a stand-alone programme, or - as an extension of the NHS Health Check programme?

    Recommendation ID PH43/11 Question How cost effective are cohort testing programmes: - as a stand-alone programme, or - as an extension

    Research recommendation
    Published
    9 June 2015

  15. How cost effective are fluoride varnish programmes and tooth-brushing schemes?

    Recommendation ID PH55/7 Question How cost effective are fluoride varnish programmes and tooth-brushing schemes? Any explanatory notes(if

    Research recommendation
    Published
    9 June 2015